MedTrace Logo

Molecular Analysis of Breast Cancer

NCT00569049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 788

Last updated 2025-02-11

No results posted yet for this study

Summary

This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis and treatment of breast cancer by identifying the molecular markers that predict clinical outcome and response to therapy.

Conditions

  • Breast Cancer
  • Breast Cancer Non-invasive Breast Cancer
  • Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Interventions

PROCEDURE

breast tissue, lymph node tissue or blood

Molecular Analyses of samples

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of California

    collaborator OTHER

  • California Breast Cancer Research Program

    collaborator OTHER

  • Breast Cancer Research Foundation

    collaborator OTHER

  • Stanford University

    lead OTHER

Principal Investigators

  • Christina Curtis, PhD, MSc · Stanford University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-05-31
Primary Completion
2011-07-01
Completion
2011-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00569049 on ClinicalTrials.gov